Scientists from ZSMU at the Charing Cross Symposium in London
On April 24-27, 2018 the Charring Cross International Symposium (CX 2018) was held in the UK. The Charing Cross Symposium (CX) started in 1978 at the Charing Cross Hospital in Hammersmith, London, and from that time till present it is considered to be the longest in Europe vascular and endovascular symposium and one of the largest in the world.
The first CX Symposium had about 100 visitors. This year, the Charing Cross symposium was held in the Olympia Grand complex, with more than 4500 participants from 85 countries registered. In this regard it is considered to be the world's largest medical event of the year.
The Assistant Professor of the Department of the Hospital Surgery, Ph.D., Oleksandr Voloshyn visited this unique Vascular Symposium and presented the scientific work: "Neutrophil to lymphocyte ratio as a marker of TASC II class in a patient with peripheral arterial disease" co-authored by Prof. A. Nikonenko, Prof. V. Gubka, and physician S. Machuiskyi. In addition, Oleksandr Voloshyn had chance to attend well-organized parallel sessions of the CX, including: CX ilegx, CX Innovation Showcase, CX Meeting with Latin America, CX Cardiovascular Course, CX Congenital defects and CX endovascular interventions. He also had the opportunity to meet and communicate with specialists in vascular and endovascular surgery who are well-known all over the world. One of them was the Head of CX for the past 40 years and the founder of BIBA Medical - the Honored Prof. of Surgery and the Head of the Department of Cardiovascular Research in Imperial College of London, UK, Roger Greenhalgh.